| Revolution Medicines, Inc. | 13.6M | US$2.54B | 11.7% |
| Electronic Arts Inc. | 7.92M | US$1.62B | 7.5% |
| Bridgebio Pharma, Inc. | 10.7M | US$800M | 3.7% |
| Protagonist Therapeutics, Inc. | 6.35M | US$778M | 3.6% |
| Exelixis, Inc. | 13.5M | US$733M | 3.4% |
| Liquidia Corporation | 8.37M | US$667M | 3.1% |
| Amazon.com, Inc. | 2.63M | US$628M | 2.9% |
| Lantheus Holdings, Inc. | 5.58M | US$619M | 2.9% |
| Natera, Inc. | 2.22M | US$602M | 2.8% |
| Unitedhealth Group Incorporated | 1.27M | US$528M | 2.4% |
| Thermo Fisher Scientific Inc | 1.05M | US$526M | 2.4% |
| Roivant Sciences Ltd. | 14.3M | US$506M | 2.3% |
| Boston Scientific Corporation | 10.5M | US$449M | 2.1% |
| Broadcom Inc. | 1.15M | US$435M | 2.0% |
| Microsoft Corp. | 1.11M | US$415M | 1.9% |
| Tango Therapeutics, Inc. | 12.3M | US$384M | 1.8% |
| Kkr & Co. Inc. | 4.12M | US$378M | 1.7% |
| Synopsys, Inc. | 830K | US$370M | 1.7% |
| Beam Therapeutics Inc. | 10.2M | US$351M | 1.6% |
| Crinetics Pharmaceuticals, Inc. | 8.99M | US$336M | 1.6% |
| Grail, Inc. | 4.16M | US$284M | 1.3% |
| Westinghouse Air Brake Technologies Corporation | 895K | US$241M | 1.1% |
| Immunovant, Inc. | 5.8M | US$224M | 1.0% |
| Twist Bioscience Corporation | 2.14M | US$220M | 1.0% |
| Agios Pharmaceuticals, Inc. | 5.92M | US$220M | 1.0% |
| Aramark | 3.63M | US$206M | 0.95% |
| Novo Nordisk A/s Class B | 2.62M | US$126M | 0.58% |
| Acadia Healthcare Company, Inc. | 4.22M | US$125M | 0.58% |
| Brightspring Health Services, Inc. | 1.73M | US$121M | 0.56% |
| Johnson & Johnson | 408K | US$104M | 0.48% |
| Parabilis Medicines, Inc. | 2.37M | US$64.8M | 0.30% |
| Novartis Ag | 363K | US$56.9M | 0.26% |
| Guardant Health, Inc. | 322K | US$48.3M | 0.22% |
| Avalo Therapeutics, Inc. | 2.5M | US$46.2M | 0.21% |
| Assembly Biosciences, Inc. | 1.6M | US$44.1M | 0.20% |
| Enanta Pharmaceuticals, Inc. | 2.42M | US$35.3M | 0.16% |
| Maze Therapeutics, Inc. | 1.11M | US$33.1M | 0.15% |
| Merck & Company, Inc. | 199K | US$25.6M | 0.12% |
| Warby Parker Inc. | 828K | US$25.1M | 0.12% |
| Perceptive Capital Solutions Corp | 2.25M | US$24.5M | 0.11% |
| Kailera Therapeutics, Inc. | 1.1M | US$24.2M | 0.11% |
| Rio Tinto Plc | 183K | US$17.4M | 0.08% |
| Axalta Coating Systems Ltd. | 478K | US$16.4M | 0.08% |
| Abivax Sa | 122K | US$16.3M | 0.08% |
| Biogen Inc. | 71,000 | US$15.3M | 0.07% |
| Taysha Gene Therapies, Inc. | 2.25M | US$15.3M | 0.07% |
| Mobia Medical, Inc. | 1.13M | US$15.1M | 0.07% |
| Minerva Neurosciences, Inc | 2.37M | US$13.1M | 0.06% |
| Alamar Biosciences, Inc. | 463K | US$12.5M | 0.06% |
| Beta Bionics, Inc. | 595K | US$9.32M | 0.04% |
| Scotts Miracle-gro Company (the) | 88,000 | US$5.99M | 0.03% |
| Waystar Holding Corp. | 265K | US$5.44M | 0.03% |
| Brunswick Corporation | 61,000 | US$5.14M | 0.02% |
| Gentex Corporation | 199K | US$5.03M | 0.02% |
| Idexx Laboratories, Inc. | 9,000 | US$4.74M | 0.02% |
| Prime Medicine, Inc. | 1.24M | US$4.58M | 0.02% |
| Commercial Metals Company | 67,000 | US$4.2M | 0.02% |
| Jatt Ii Acquisition Corp | 300K | US$3.41M | 0.02% |
| Sagimet Biosciences Inc. - Series A | 415K | US$3.21M | 0.01% |
| Summit Midstream Corporation | 58,214 | US$1.66M | <0.01% |
| Teva Pharmaceutical Industries Limited | 40,000 | US$1.36M | <0.01% |
| Cogent Biosciences, Inc. | 17,000 | US$658K | <0.01% |
| Aleanna, Inc. | 78,400 | US$227K | <0.01% |
| Welltower Inc. | 1,000 | US$227K | <0.01% |
| Pacific Biosciences Of California, Inc. | 14,200 | US$23,856 | <0.01% |
| Geron Corporation | 14,400 | US$18,432 | <0.01% |
| Canopy Growth Corporation | 18,000 | US$17,100 | <0.01% |
| Rani Therapeutics Holdings, Inc. | 20,700 | US$15,740 | <0.01% |
| Beyond Meat, Inc. | 19,000 | US$14,250 | <0.01% |
| Nuvation Bio Inc. | 0 | US$0 | 0.00% |
| Ocular Therapeutix, Inc. | 0 | US$0 | 0.00% |
| Omeros Corporation | 0 | US$0 | 0.00% |
| Opus Genetics, Inc. | 0 | US$0 | 0.00% |
| Oscar Health, Inc. | 0 | US$0 | 0.00% |
| Piper Sandler Companies | 0 | US$0 | 0.00% |
| Precigen, Inc. | 0 | US$0 | 0.00% |
| Progyny, Inc. | 0 | US$0 | 0.00% |
| Rollins, Inc. | 0 | US$0 | 0.00% |
| S&p Global Inc. | 0 | US$0 | 0.00% |
| Sabra Health Care Reit, Inc. | 0 | US$0 | 0.00% |
| Scholar Rock Holding Corporation | 0 | US$0 | 0.00% |
| Schrodinger, Inc. | 0 | US$0 | 0.00% |
| Charles Schwab Corporation (the) | 0 | US$0 | 0.00% |
| Sellas Life Sciences Group, Inc. | 0 | US$0 | 0.00% |
| Servicenow, Inc. | 0 | US$0 | 0.00% |
| Stoke Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Supernus Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Syndax Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Tenable Holdings, Inc. | 0 | US$0 | 0.00% |
| Tenet Healthcare Corporation | 0 | US$0 | 0.00% |
| Terns Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Timken Company (the) | 0 | US$0 | 0.00% |
| Travere Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Tvardi Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Tyra Biosciences, Inc. | 0 | US$0 | 0.00% |
| Vaxcyte, Inc. | 0 | US$0 | 0.00% |
| Veracyte, Inc. | 0 | US$0 | 0.00% |
| Vertiv Holdings, Llc | 0 | US$0 | 0.00% |
| Vir Biotechnology, Inc. | 0 | US$0 | 0.00% |
| Visa Inc. | 0 | US$0 | 0.00% |